Girard Sharp is investigating potential securities claims on behalf of former or current investors of 3M Company (“3M”) who received shares of Neogen Corporation (“Neogen” or the “Company”) in connection with Neogen’s acquisition of 3M’s Food Safety Business on September 1, 2022 (“Merger”).

If you are a former or current 3M investor who received Neogen shares in the September 2022 Merger, you may have a claim for relief.

Speak to a Girard Sharp attorney about your rights and your eligibility for relief. Please fill out our form or call (866) 981-4800 for a free consultation.

Neogen (NASDAQ: NEOG) Merger Stock Plummets By 75%

Neogen is a Michigan corporation that, with its subsidiaries, “manufacture and market a diverse line of products and services dedicated to food and animal safety.”  In connection with the Merger, the Company had projected improved margins and stronger free cash flow, but after the Merger, its stock price fell by 75%.

Our Commitment to Excellence

Girard Sharp represents investors, consumers, and institutions in class actions and other complex litigation nationwide. We serve on the Plaintiffs’ executive committee in the recent spoofing litigation against JPMorgan Chase that settled for $60 million, a favorable resolution that the district court preliminarily approved in December 2021. We recently obtained a $36.5 million securities settlement against Maxar Technologies, a space imagery company, after its share price collapsed following its acquisition of DigitalGlobe. Our attorneys have obtained multimillion-dollar recoveries for victims of unfair and deceptive practices in antitrust, financial fraud, and consumer protection matters against some of the country’s largest corporations, including Raymond James, John Hancock, and Sears. Girard Sharp has earned top-tier rankings from U.S. News and World Report for Securities and Class Action Litigation and has been repeatedly selected as an Elite Trial Lawyers finalist by the National Law Journal.